Insys Therapeutics, Inc. (INSY) stock prices updated...
 

Insys Therapeutics, Inc. stock price

Insys Therapeutics, Inc. latest news:


  • 09/06/2017 15:48:56

    U.S. senator reveals results of opioid inquiry into Insys

    BOSTON, Sept 6 (Reuters) - Insys Therapeutics Inc sought to manipulate the process to gain insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report related to the national opioid addiction crisis released on Wednesday.

  • 08/18/2017 13:27:02

    UPDATE 1-Insys agrees to pay $4.45 mln to resolve Illinois opioid lawsuit

    BOSTON, Aug 18 (Reuters) - Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.

  • 07/13/2017 16:46:43

    Anthem files lawsuit against Insys Therapeutics

    July 13 (Reuters) - Health insurer Anthem Inc filed a lawsuit against Insys Therapeutics Inc on Wednesday, alleging the drugmaker fraudulently obtained reimbursements for its opioid painkiller Subsys.

  • More trends:

    Intec Pharma Ltd.NTEC | Integra LifeSciences Holdings CorporationIART | Integrated Device Technology, Inc.IDTI | Integrated Electrical Services, Inc.IESC | Integrated Silicon Solution, Inc.ISSI | Intel CorporationINTC | Inteliquent, Inc.IQNT | Intellipharmaceutics International Inc.IPCI | Inter Parfums, Inc.IPAR | Interactive Brokers Group, Inc.IBKR |